Filing Flows › Cumberland Pharmaceuticals (CPIX) › Capital expenditures
Cumberland Pharmaceuticals (CPIX) capital expenditures by quarter
Cumberland Pharmaceuticals' capital expenditures were $38K in Q2 2026 (second quarter 2026), +61% from Q3 2025. Over the last 5 quarters it ranged from $2K (Q4 2024) to $48K (Q1 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $38K | +61% | +45% |
| Q3 2025 | $24K | -10% | — |
| Q2 2025 | $26K | -44% | — |
| Q1 2025 | $48K | 21× | — |
| Q4 2024 | $2K | — | — |
Q2 2026 at a glance
Cumberland Pharmaceuticals, Q2 2026: revenue $8.8M (-19% year over year), operating margin -35.9%, net loss $4.3M, operating cash flow $169K. The chart follows the revenue to costs, profit and cash.
Questions
What is Cumberland Pharmaceuticals' capital expenditures?
Cumberland Pharmaceuticals' capital expenditures were $38K in Q2 2026 (second quarter 2026), +61% from Q3 2025.
How has Cumberland Pharmaceuticals' capital expenditures changed?
Over the last 5 quarters it ranged from $2K (Q4 2024) to $48K (Q1 2025).
Q2 2026 results → · How Cumberland Pharmaceuticals makes money →